Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in RAGE activation signaling pathways

Journal of Cellular Physiology

Volumn 226, Issue 6, 2011, Pages 1554-1563

  Kamioka, Masashi ^a   Ishibashi, Toshiyuki ^a,b   Ohkawara, Hiroshi ^a   Nagai, Ryoji ^c   Sugimoto, Koichi ^a   Uekita, Hironori ^a   Matsui, Takanori ^d   Yamagishi, Sho Ichi ^d   Ando, Katsuya ^a   Sakamoto, Takayuki ^a   Sakamoto, Nobuo ^a   Takuwa, Yoh ^e   Wada, Ikuo ^a   Shiomi, Masashi ^f   Maruyama, Yukio ^g   Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

^c JAPAN WOMEN'S UNIVERSITY   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g HOSHI GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; GERANYLGERANYL TRANSFERASE I; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE 14; PROTEIN P47; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RABBIT; RAT; SMOOTH MUSCLE FIBER;

ALKYL AND ARYL TRANSFERASES; ANIMALS; ATHEROSCLEROSIS; ENZYME ACTIVATION; GENE SILENCING; GLYCOSYLATION END PRODUCTS, ADVANCED; MATRIX METALLOPROTEINASE 14; NADPH OXIDASE; NF-KAPPA B; OXIDATION-REDUCTION; PROTEIN BINDING; RABBITS; RAC1 GTP-BINDING PROTEIN; RATS; RECEPTORS, IMMUNOLOGIC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 79952731418     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22492     Document Type: Article

References (44)

1. Baker AH, Edwards DR, Murphy G. 2002. Metalloproteinase inhibitors: Biological actions and therapeutic opportunities. J Cell Sci 115: 3719-3727.
2. Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R. 2004. Morphologic findings of coronary atherosclerotic plaques in diabetics: A postmortem study. Arterioscler Thromb Vasc Biol 24: 1266-1277.
3. Cipollone F, Iezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C, De Cesare D, De Blasis G, Muraro R, Bei R, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A. 2003. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: Role of glycemic control. Circulation 108: 1070-1077.
4. Dong Z, Bonfil RD, Chinni S, Deng X, Trindade Filho JC, Bernardo M, Vaishampayan U, Che M, Sloane BF, Sheng S, Fridman R, Cher ML. 2005. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. Am J Pathol 166: 1173-1186.
5. Galis ZS, Khatri JJ. 2002. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 90: 251-262.
6. Giacchetti G, Sechi LA, Rilli S, Carey RM. 2005. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab 16: 120-126.
7. Goldin A, Beckman JA, Schmidt AM, Creager MA. 2006. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 114: 597-605.
8. Golovchenko I, Goalstone ML, Watson P, Brownlee M, Draznin B. 2000. Hyperinsulinemia enhances transcriptional activity of nuclear factor-κB induced by angiotensin-II, hyperglycemia, and advanced glycation end products in vascular smooth muscle cells. Circ Res 87: 746-752.
9. Hudson BI, Kalea AZ, Del Mar Arriero M, Harja E, Boulanger E, D'Agati V, Schmidt AM. 2008. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem 283: 34457-34468.
10. Ishibashi T, Sakamoto T, Ohkawara H, Nagata K, Sugimoto K, Sakurada S, Sugimoto N, Watanabe A, Yokoyama K, Sakamoto N, Kurabayashi M, Takuwa Y, Maruyama Y. 2003. Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells. Arterioscler Thromb Vasc Biol 23: 681-687.
11. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M. 2001. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153: 893-904.
12. Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ, Jr., Taguchi A, Olson K, Bucciarelli L, Goova M, Hofmann MA, Cataldegirmen G, D'Agati V, Pischetsrieder M, Stern DM, Schmidt AM. 2001. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 21: 905-910.
13. -/- mice. J Clin Invest 118: 183-194.
14. Langlois S, Gingras D, Beliveau R. 2004. Membrane type 1-matrix metalloproteinase cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood 103: 3020-3028.
15. Lehti K, Allen E, Birkedal-Hansen H, Holmbeck K, Miyake Y, Chun TH, Weiss SJ. 2005. An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature. Genes Dev 19: 979-991.
16. Li L, Matsuoka I, Suzuki Y, Watanabe Y, Ishibashi T, Yokoyama K, Maruyama Y, Kimura J. 2002. Inhibitory effect of fluvastatin on lysophosphatidylcholine-induced nonselective cation current in Guinea pig ventricular myocytes. Mol Pharmacol 62: 602-607.
17. Masuyama T, Komeda K, Hara A, Noda M, Shinohara M, Oikawa T, Kanazawa Y, Taniguchi K. 2004. Chronological characterization of diabetes development in male spontaneously diabetic Torii rats. Biochem Biophys Res Commun 314: 870-877.
18. Monnier VM, Cerami A. 1981. Nonenzymatic browning in vivo: Possible process for aging of long-lived proteins. Science 211: 491-493.
19. Nagai R, Matsumoto K, Ling X, Suzuki H, Araki T, Horiuchi S. 2000. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49: 1714-1723.
20. Nagai R, Mera K, Nakajou K, Fujiwara Y, Iwao Y, Imai H, Murata T, Otagiri M. 2007. The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs. Biochim Biophys Acta 1772: 1192-1198.
21. Ohkawara H, Ishibashi T, Sakamoto T, Sugimoto K, Nagata K, Yokoyama K, Sakamoto N, Kamioka M, Matsuoka I, Fukuhara S, Sugimoto S, Takuwa Y, Maruyama Y. 2005. Thrombin-induced rapid geranylgeranylation of RhoA as an essential process for RhoA activation in endothelial cells. J Biol Chem 280: 10182-10188.
22. Okumura AJ, Hatsuzawa K, Tamura T, Nagaya H, Saeki K, Okumura F, Nagao K, Nishikawa M, Yoshimura A, Wada I. 2006. Involvement of a novel Q-SNARE, D12, in quality control of the endomembrane system. J Biol Chem 281: 4495-4506.
23. Rajavashisth TB, Liao JK, Galis ZS, Tripathi S, Laufs U, Tripathi J, Chai NN, Xu XP, Jovinge S, Shah PK, Libby P. 1999a. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 274: 11924-11929.
24. Rajavashisth TB, Xu XP, Jovinge S, Meisel S, Xu XO, Chai NN, Fishbein MC, Kaul S, Cercek B, Sharifi B, Shah PK. 1999b. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: Evidence for activation by proinflammatory mediators. Circulation 99: 3103-3109.
25. Rozanov DV, Hahn-Dantona E, Strickland DK, Strongin AY. 2004. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells. J Biol Chem 279: 4260-4268.
26. Ryu Y, Takuwa N, Sugimoto N, Sakurada S, Usui S, Okamoto H, Matsui O, Takuwa Y. 2002. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. Circ Res 90: 325-332.
27. 2+ influx through MCP-1 in endothelial cells by monocyte adhesion. Arterioscler Thromb Vasc Biol 25: 2005-2011.
28. 2+ signaling. Atherosclerosis 193: 44-54.
29. 2+ signaling pathways in endothelial cells. J Cell Physiol 220: 706-715.
30. Schmidt AM, Stern DM. 2000. RAGE: A new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends Endocrinol Metab 11: 368-375.
31. Schneider F, Sukhova GK, Aikawa M, Canner J, Gerdes N, Tang SM, Shi GP, Apte SS, Libby P. 2008. Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques. Circulation 117: 931-939.
32. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. 2002. Angiotensin II stimulation of NAD(P)H oxidase activity: Upstream mediators. Circ Res 91: 406-413.
33. Shindo J, Ishibashi T, Yokoyama K, Nakazato K, Ohwada T, Shiomi M, Maruyama Y. 1999. Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits. Circulation 99: 2150-2156.
34. Shiomi M, Ito T, Yamada S, Kawashima S, Fan J. 2003. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler Thromb Vasc Biol 23: 1239-1244.
35. Shofuda T, Shofuda K, Ferri N, Kenagy RD, Raines EW, Clowes AW. 2004. Cleavage of focal adhesion kinase in vascular smooth muscle cells overexpressing membrane-type matrix metalloproteinases. Arterioscler Thromb Vasc Biol 24: 839-844.
36. Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, Thomas M, Forbes JM, Nawroth PP, Bierhaus A, Cooper ME, Jandeleit-Dahm KA. 2008. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 57: 2461-2469.
37. Stawowy P, Meyborg H, Stibenz D, Stawowy NB, Roser M, Thanabalasingam U, Veinot JP, Chretien M, Seidah NG, Fleck E, Graf K. 2005. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-promatrix metalloproteinase-2 proteolytic cascade in atherosclerosis. Circulation 111: 2820-2827.
38. Sugimoto K, Ishibashi T, Sawamura T, Inoue N, Kamioka M, Uekita H, Ohkawara H, Sakamoto T, Sakamoto N, Okamoto Y, Takuwa Y, Kakino A, Fujita Y, Tanaka T, Teramoto T, Maruyama Y, Takeishi Y. 2009. LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. Cardiovasc Res 84: 127-136.
39. Tsao PS, Wang B, Buitrago R, Shyy JY, Cooke JP. 1997. Nitric oxide regulates monocyte chemotactic protein-1. Circulation 96: 934-940.
40. Yamagishi S, Matsui T, Nakamura K, Takeuchi M. 2005. Minodronate, a nitrogen-containing bisphosphonate, inhibits advanced glycation end product-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation. Int J Tissue React 27: 189-195.
41. Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T. 2006. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem 281: 20213-20220.
42. Yokoyama K, Ishibashi T, Ohkawara H, Kimura J, Matsuoka I, Sakamoto T, Nagata K, Sugimoto K, Sakurada S, Maruyama Y. 2002. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells. Circulation 105: 962-967.
43. Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Takeuchi M, Ueno T, Sata M. 2006. Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product (AGE)-induced C-reactive protein expression in hepatoma cells by suppressing Rac-1 activation. FEBS Lett 580: 2788-2796.
44. Zhang M, Kho AK, Anilkumar N, Chibber R, Pagano PJ, Shah AM, Cave AC. 2006. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: Involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 113: 1235-1243.